OBJECTIVES: The aim of this study is to identify the molecular characteristics of erythromycin-resistant (Erm(r)) Streptococcus agalactiae strains and to correlate with the clinical origin of strains. METHODS: From 711 S. agalactiae strains, 119 Erm(r) strains (17%) were collected, serotyped and screened for macrolide resistance genes. The genetic relationship between strains was established by the PFGE analysis. Strains were tested for the group II intron GBSi1 downstream of the scpB gene, IS1548 in the hylB gene, four prophage DNA fragments and a lineage defined by multilocus sequence typing as ST-17. RESULTS: Erythromycin resistance involved 8% of serotype Ia, 15% of serotype Ib, 9% of serotype II, 16% of serotype III, 31% of serotype IV and 35% of serotype V. The prevalence of Erm(r) strains was higher among strains isolated from the gastric fluid of neonates (33%) than in those isolated from bacteraemia and meningitis during early-onset disease (EOD) or late-onset disease (7% and 11%) (P = 0.001). In serotype III, Erm(r) strains were more frequent in vaginal carriage (22%) and colonized neonates (18%) than in EOD (0%) (P = 0.03). The mef(A) gene was the most common in serotype Ia (55%), the erm(A) gene in serotype Ib (75%) and the erm(B) gene in the other serotypes (56% to 75%). All resistant strains with IS1548 also had the erm(B) gene. Erm(r) strains were not randomly distributed in the different PFGE genogroups, and 11% had the GBSi1 intron, 37% had at least one prophage DNA fragment and 7% belonged to ST-17. CONCLUSIONS: Erythromycin resistance varied according to the clinical origin, serotype and molecular characteristics of S. agalactiae strains.
OBJECTIVES: The aim of this study is to identify the molecular characteristics of erythromycin-resistant (Erm(r)) Streptococcus agalactiae strains and to correlate with the clinical origin of strains. METHODS: From 711 S. agalactiae strains, 119 Erm(r) strains (17%) were collected, serotyped and screened for macrolide resistance genes. The genetic relationship between strains was established by the PFGE analysis. Strains were tested for the group II intron GBSi1 downstream of the scpB gene, IS1548 in the hylB gene, four prophage DNA fragments and a lineage defined by multilocus sequence typing as ST-17. RESULTS:Erythromycin resistance involved 8% of serotype Ia, 15% of serotype Ib, 9% of serotype II, 16% of serotype III, 31% of serotype IV and 35% of serotype V. The prevalence of Erm(r) strains was higher among strains isolated from the gastric fluid of neonates (33%) than in those isolated from bacteraemia and meningitis during early-onset disease (EOD) or late-onset disease (7% and 11%) (P = 0.001). In serotype III, Erm(r) strains were more frequent in vaginal carriage (22%) and colonized neonates (18%) than in EOD (0%) (P = 0.03). The mef(A) gene was the most common in serotype Ia (55%), the erm(A) gene in serotype Ib (75%) and the erm(B) gene in the other serotypes (56% to 75%). All resistant strains with IS1548 also had the erm(B) gene. Erm(r) strains were not randomly distributed in the different PFGE genogroups, and 11% had the GBSi1 intron, 37% had at least one prophage DNA fragment and 7% belonged to ST-17. CONCLUSIONS:Erythromycin resistance varied according to the clinical origin, serotype and molecular characteristics of S. agalactiae strains.
Authors: Sarah Teatero; Taryn B T Athey; Paul Van Caeseele; Greg Horsman; David C Alexander; Roberto G Melano; Aimin Li; Anthony R Flores; Samuel A Shelburne; Allison McGeer; Walter Demczuk; Irene Martin; Nahuel Fittipaldi Journal: J Clin Microbiol Date: 2015-07-01 Impact factor: 5.948
Authors: S Corvec; M Illiaquer; S Touchais; D Boutoille; N van der Mee-Marquet; R Quentin; A Reynaud; D Lepelletier; P Bémer Journal: J Clin Microbiol Date: 2010-11-10 Impact factor: 5.948
Authors: C-R Usein; L Grigore; R Georgescu; V Cristea; M Bãltoiu; M Strãuţ Journal: Eur J Clin Microbiol Infect Dis Date: 2012-02-23 Impact factor: 3.267
Authors: Brigitte Malbruny; Anja M Werno; David R Murdoch; Roland Leclercq; Vincent Cattoir Journal: Antimicrob Agents Chemother Date: 2011-01-18 Impact factor: 5.191
Authors: Mazen Salloum; Nathalie van der Mee-Marquet; Anne-Sophie Valentin-Domelier; Roland Quentin Journal: PLoS One Date: 2011-05-25 Impact factor: 3.240
Authors: Clément Lier; Elodie Baticle; Philippe Horvath; Eve Haguenoer; Anne-Sophie Valentin; Philippe Glaser; Laurent Mereghetti; Philippe Lanotte Journal: Front Genet Date: 2015-06-15 Impact factor: 4.599